These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 20031096

  • 21. The effectiveness of high-dosage amisulpride combined with moderate-dosage sodium valproate treatment for an overweight patient with psychotic bipolar disorder.
    Hou YC, Lai CH.
    J Neuropsychiatry Clin Neurosci; 2014 Apr 01; 26(2):E34-5. PubMed ID: 24763785
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T, Brown E, Schuh LM, Baker RW, Tohen M.
    J Affect Disord; 2005 Dec 01; 89(1-3):69-77. PubMed ID: 16253344
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders.
    Hellewell JS.
    J Psychopharmacol; 2006 Mar 01; 20(2 Suppl):39-45. PubMed ID: 16551671
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Long-term therapy with intuition].
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():87. PubMed ID: 14579492
    [No Abstract] [Full Text] [Related]

  • 29. Divalproex in the treatment of bipolar disorder.
    Keck PE, McElroy SL.
    Psychopharmacol Bull; 2003 May 26; 37 Suppl 2():67-73. PubMed ID: 15021862
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation.
    Olson DA, Ingram W, Mann JR.
    J Clin Psychopharmacol; 2002 Oct 26; 22(5):529-30. PubMed ID: 12352281
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH, DelBello MP, Adler CM, Stanford KE, Strakowski SM.
    J Child Adolesc Psychopharmacol; 2006 Dec 26; 16(6):665-70. PubMed ID: 17201610
    [Abstract] [Full Text] [Related]

  • 34. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
    Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW.
    Am J Psychiatry; 2003 Jul 26; 160(7):1263-71. PubMed ID: 12832240
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.
    Garnham J, Munro A, Slaney C, Macdougall M, Passmore M, Duffy A, O'Donovan C, Teehan A, Alda M.
    J Affect Disord; 2007 Dec 26; 104(1-3):185-90. PubMed ID: 17442400
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.